Owner only: item control page
Tzaridis, Theophilos 
; Schäfer, Niklas ; Weller, Johannes ; Steinbach, Joachim‐Peter ; Schlegel, Uwe ; Seidel, Sabine ; Sabel, Michael ; Hau, Peter ; Seidel, Clemens ; Krex, Dietmar ; Goldbrunner, Roland ; Tonn, Jörg‐Christian ; Grauer, Oliver ; Kebir, Sied ; Schneider, Matthias ; Schaub, Christina ; Vatter, Hartmut ; Coch, Christoph ; Glas, Martin ; Fimmers, Rolf ; Pietsch, Torsten ; Reifenberger, Guido ; Herrlinger, Ulrich ; Felsberg, Jörg
; Schäfer, Niklas ; Weller, Johannes ; Steinbach, Joachim‐Peter ; Schlegel, Uwe ; Seidel, Sabine ; Sabel, Michael ; Hau, Peter ; Seidel, Clemens ; Krex, Dietmar ; Goldbrunner, Roland ; Tonn, Jörg‐Christian ; Grauer, Oliver ; Kebir, Sied ; Schneider, Matthias ; Schaub, Christina ; Vatter, Hartmut ; Coch, Christoph ; Glas, Martin ; Fimmers, Rolf ; Pietsch, Torsten ; Reifenberger, Guido ; Herrlinger, Ulrich ; Felsberg, Jörg MGMT promoter methylation analysis for allocating combined CCNU / TMZ chemotherapy: Lessons learned from the CeTeG / NOA ‐09 trial
Tzaridis, Theophilos, Schäfer, Niklas, Weller, Johannes, Steinbach, Joachim‐Peter, Schlegel, Uwe, Seidel, Sabine, Sabel, Michael, Hau, Peter, Seidel, Clemens, Krex, Dietmar, Goldbrunner, Roland, Tonn, Jörg‐Christian, Grauer, Oliver, Kebir, Sied, Schneider, Matthias, Schaub, Christina, Vatter, Hartmut, Coch, Christoph, Glas, Martin, Fimmers, Rolf, Pietsch, Torsten, Reifenberger, Guido, Herrlinger, Ulrich and Felsberg, Jörg
(2021)
MGMT promoter methylation analysis for allocating combined CCNU / TMZ chemotherapy: Lessons learned from the CeTeG / NOA ‐09 trial.
International Journal of Cancer 148 (7), pp. 1695-1707.
Date of publication of this fulltext: 11 Oct 2021 13:10
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | International Journal of Cancer | ||||
| Publisher: | Wiley | ||||
|---|---|---|---|---|---|
| Place of Publication: | HOBOKEN | ||||
| Volume: | 148 | ||||
| Number of Issue or Book Chapter: | 7 | ||||
| Page Range: | pp. 1695-1707 | ||||
| Date | 2021 | ||||
| Institutions | Medicine > Lehrstuhl für Neurologie | ||||
| Identification Number |
| ||||
| Keywords | NEWLY-DIAGNOSED GLIOBLASTOMA; OPEN-LABEL; TEMOZOLOMIDE; BEVACIZUMAB; LOMUSTINE; MODEL; CCNU; TMZ; glioblastoma; MGMT promoter methylation | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 50617 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric